Promyelocytic leukemia protein targets MK2 to promote cytotoxicity

I‐Ting Chen(Institute of Molecular Biology, Academia Sinica), Ming‐Zong Lai(Institute of Molecular Biology, Academia Sinica), Fu‐Yi Hsieh(Institute of Molecular Biology, Academia Sinica), Hsiao‐Chi Chen(Baylor College of Medicine), Hsiu‐Ming Shih(University of Minnesota), Yu‐Hsun Lo(Institute of Molecular Biology, Academia Sinica), Yung‐Hsuan Wu(Institute of Molecular Biology, Academia Sinica), Peng‐Yeh Lai(Institute of Molecular Biology, Academia Sinica)
EMBO Reports
October 11, 2021
10.15252/embr.202052254
Cited by 7

Related Papers

Remote neuronal activity drives glioma progression through SEMA4F
|Nature|2023|172
Growth Hormone Induction of Hepatic Serine Protease Inhibitor 2.1 Transcription Is Mediated by a Stat5-related Factor Binding Synergistically to Two γ-Activated Sites
|Journal of Biological Chemistry|1995|118
ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma
|Cancer Discovery|2021|90
Inhibitory input directs astrocyte morphogenesis through glial GABABR
|Nature|2023|76
Participation of c-FLIP in NLRP3 and AIM2 inflammasome activation
|Cell Death and Differentiation|2013|72